Quality Digest
Published: Tuesday, January 23, 2007 - 23:00 The RCG’s team members include former FDA employees who have extensive knowledge of the agency’s requirements. The group specializes in guiding clients through the FDA’s new process analytical technology, which represents a shift away from the agency’s traditional product-centric inspection approach to a more process-centric approach that accounts for the myriad variables that affect product quality. “Because Pharmatech recognizes the challenges facing the FDA and industry to coordinate and review compliance activities, we have developed a project management structure to leverage the strengths of each piece of the compliance puzzle,” says Calvin Wong, Pharmatech’s CEO. Pharmatech is a consultancy that specializes in services to the life sciences market. For more information, visit www.pharmatechassociates.com. For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.
FDA Compliance Pharmatech Establishes Regulatory Compliance Group
Pharmatech Associates Inc. has established a Regulatory Compliance Group that’s designed to help the consultancy’s clients ensure long-term drug development compliance with Food and Drug Administration regulations.
About The Author
Quality Digest
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.
